Respiratory

Incidence Rates for an Extensive List of Adverse Events of Special Interest in the Pre-COVID-19 and Active COVID-19 Eras: A Comprehensive Source for Representative Historical Background Rates in the US General Population

Incidence Rates for an Extensive List of Adverse Events of Special Interest in the Pre-COVID-19 and Active COVID-19 Eras: A Comprehensive Source for Representative Historical Background Rates in the US General Population

Characterization of Long-COVID Phenotypes and Associated Clinical Phenotypes in Administrative Claims Data

Characterization of Long-COVID Phenotypes and Associated Clinical Phenotypes in Administrative Claims Data

Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US

Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US

Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data

Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data

SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes

SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes

A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022

A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022

Estimating real-world treatment effects under a rapidly evolving treatment paradigm

Estimating real-world treatment effects under a rapidly evolving treatment paradigm

Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data

Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data

Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology

Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology